It's important for individuals with asthma to be aware of the potential risks associated with this treatment and to speak with their healthcare provider about alternative options
Receptor activity
10 mg blend vial (5 mg CJC + 5 mg Ipamorelin) reconstituted with 1 ml BAC water = 10 mg/ml
treated with dipeptidyl peptidase 4 (DPP-4) inhibitors, including sitagliptin, vildagliptin, saxagliptin, linagliptin, gemigliptin, teneligliptin, alogliptin, evogliptin, and anagliptin ( n =64,269)
Storage Conditions: Store in a cool, dry, and dark place away from direct heat, light, and moisture
All statistical analyses were performed using PRISM 10.3.0 software (GraphPad, San Diego, CA)